Searched for
DILIP SHANGHVI DEAL
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...27 Apr, 2026, 02.24 PM IST- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...27 Apr, 2026, 10.33 AM IST
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...24 Apr, 2026, 08.17 AM IST
- Sun Pharma promoters take a hit on personal investmentsSome of their biggest personal investments have been in power and real estate, and both sectors and their holdings have taken a beating, ac...11 Dec, 2018, 09.25 AM IST
- Open offer to acquire 26 per cent stake in Suzlon draws poor responseUnder the open offer, Shanghvi and associates had to acquire 26 per cent stake for Rs 2,837 crore in the wind turbine maker.20 Jan, 2016, 08.41 PM IST
- Dilip Shanghvi, promoters to make open offer to buy 26% Suzlon stakeDilip Shanghvi- controlled entities along with promoters of Suzlon will make an open offer worth Rs 2,837 crore to acquire 26% stake in the...16 Dec, 2015, 10.56 PM IST
- Here's a snapshot of Sun Pharmaceutical's acquisitions and turnaround storiesExperts say there are three key tests — a substantial improvement opportunity, strategic fit for existing businesses and reasonable price.21 Sep, 2015, 04.47 AM IST
- Competition Commission approves Dilip Shanghvi's proposed Rs 1,800-crore deal with SuzlonThe deal, announced in February this year, would see Shanghvi acquiring at least 23 per cent stake in Suzlon which has been grappling with ...08 May, 2015, 09.23 PM IST
- Dilip Shanghvi in talks for a stake buy in ABG ShipyardTroubled shipbuilder ABG Shipyard is looking for a white knight and it's now pinning hopes on India's richest man Dlilip Shanghvi for a bai...02 Apr, 2015, 12.58 PM IST
- Need to regain trust of regulators post Ranbaxy deal: Dilip Shanghvi, Sun PharmaIn an interview with ET Now, Nirmal Jain, chairman, IIFL Group, and R Venkataraman, managing director, share their views on markets.26 Mar, 2015, 01.27 PM IST
- Sun Pharma executives bag top slots in company after Ranbaxy mergerMost executives from Ranbaxy's earlier team have already left the company in past one year.12 Mar, 2015, 11.49 AM IST
- Sun Pharmaceuticals founder Dilip Shanghvi in talks to acquire stake in Suzlon EnergyDilip Shanghvi's brother-in-law Sudhir Valia will provide Rs 4,000 crore, which the debt-hit Suzlon will use to meet its working capital ne...13 Feb, 2015, 11.19 AM IST
- Sun Pharma chief Dilip S Shanghvi expects Ranbaxy deal to be closed by mid-FebruaryDilip S Shanghvi expects the Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined ...25 Jan, 2015, 11.34 AM IST
- ET Awards 2014: Sun Pharma's Dilip Shanghvi is Business Leader of the yearThe low-key, but persistent, managing director of Sun Pharmaceutical Industries is a self-made billionaire.01 Oct, 2014, 09.39 AM IST
- Sun Pharma denies insider trading charges in Ranbaxy dealSun Pharma denied insider trading charges against Silverstreet Developers- its wholly owned arm - in the $4 bn acquisition deal of Ranbaxy ...10 Apr, 2014, 07.06 AM IST
- Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touchHis staff call him India's most aggressive promoter whose calm demeanour shadows his killer instincts when it comes to splurging on riskies...08 Apr, 2014, 02.16 AM IST
- Ranbaxy deal fabulous for Sun Pharma: Ajay PiramalSun Pharma will be in a better position to manage Ranbaxy. They have handled overseas acquisitions successfully, says Ajay Piramal.08 Apr, 2014, 02.05 AM IST
Load More
